Safety and Efficacy of Ibrutinib in Combination with Venetoclax in Patients with Marginal Zone Lymphoma: Preliminary Results from an Open Label, Phase II Study

Sasanka M. Handunnetti; Amit Khot; Mary Ann Anderson; Piers Blombery; Kate Burbury; David Ritchie; Rodney J. Hicks; Besiat Birbirsa; Mathias Bressel; Juliana Di Iulio; David Westerman; Stephen Lade; Andrew W. Roberts; John F. Seymour; Constantine S. Tam

doi:10.1182/blood-2019-126396

Related publications

Article2025

Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma

Sasanka M. Handunnetti, Amit Khot, Piers Blombery, Kate Burbury, Philip A. Thompson, David Ritchie, Rodney J. Hicks, Glenda Burke, Rachel Koldej, Mathias Bressel, Juliana L Di Iulio, David Westerman, Stephen Lade, John F. Seymour, Constantine S. Tam, Mary Ann Anderson

Article2024

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Marco Herling, Claire Dearden, Francesco Zaja, Dima El‐Sharkawi, Wei Ding, Mar Bellido, Amit Khot, Lidwine W. Tick, Eric D. Jacobsen, Toby A. Eyre, Damien Roos‐Weil, Tapan Kadia, Elisa Lucchini, Natali Pflug, Matthew S. Davids, Germán Peña, Nabanita Mukherjee, Mohamed Badawi, Tamas Vizkelety, Philipp B. Staber

Article2015

Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)

Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeffrey Matous, David MacDonald, Constantine S. Tam, O. Tournilhac, Shuo Ma, Albert Oriol, Leonard T. Heffner, Chaim Shustik, Ramón García‐Sánz, Robert F. Cornell, Carlos Fernández de Larrea, Jorge J. Castillo, Miquel Granell, Marie‐Christine Kyrtsonis, Véronique Leblond, Argiris Symeonidis, Priyanka Singh, Jianling Li,

Article2008

Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: Promising results in marginal zone lymphoma

Theofanis Economopoulos, Amanda Psyrri, George Fountzilas, Constantinos Tsatalas, Αchilles Anagnostopoulos, Sotirios G. Papageorgiou, Nikolaos I. Xiros, Meletios A Dimopoulos

Article2020

A phase III, randomized, multicenter, open-label study of venetoclax or pomalidomide in combination with dexamethasone in patients with t(11;14)-positive relapsed/refractory multiple myeloma.

María‐Victoria Mateos, Philippe Moreau, Meletios A Dimopoulos, Wan‐Jen Hong, Scott Cooper, Yao Yu, Muhammad Jalaluddin, Jeremy A. Ross, Sudeep Karve, Sheryl Coppola, Paulo Maciag, Orlando F. Bueno, Emma Arriola, Shaji Kumar